Zsa Zsa Gabor rushed back to the hospital
EPA/ISTVAN BAJZATZsa Zsa Gabor has been rushed back to the UCLA Ronald Reagan Medical Center after her husband called 911 earlier today.
Archive for Medical
Posted by admin on September 3rd, 2010
Study Finds Marijuana May Indeed Offer Relief for Chronic Pain
The topic of medical marijuana is often a heated debate, but new research shows that cannabis could offer help for those suffering from chronic neuropathic pain from nerve injury.
Results of the study by McGill University and the McGill University Health Centre are published in the Canadian Medical Association Journal, and they suggest other health benefits such as improved mood and better sleep also come from smoking low doses of marijuana.
The researchers used herbal cannabis from a supplier who is under contract to legally distribute marijuana for research and medical purposes and also placebo form of the drug from the US
The results that showed the most promise stemmed from a specific medication method — 25 milligrams of marijuna containing about 10 percent of its active ingredient THC, smoked as a single inhalation by pipe three times a day, over a period of five days.
This is the first trial to be conducted where patients have been allowed to smoke cannabis at home and to monitor their responses, daily, lead author, Dr. Mark Ware, director of clinical research at the Alan Edwards Pain Management Unit at the MUHC, said in a news release.
Ware, who is also an assistant professor of anesthesia at McGill University and a neuroscience researcher at the Research Institute of the MUHC, said that most of the study participants suffered pain as a result of injuries from car accidents or cut nerves during surgery.
This kind of pain occurs more frequently than many people recognize, and there are few effective treatments available, he said in a statement. For these patients, medical cannabis is sometimes seen as their last hope.
Further studies are needed to confirm the proper dosage, quality and length of time that medical marijuana should be used to safely aid people suffering from pain.
Our challenge as researchers is to continue to conduct rigorous clinical studies on the medical use of cannabis, Ware said. This will allow us to move the debate forward by providing reliable scientific clinical data.
More on Medical Marijuana:
Using Pot as Medicine: Petes Story
Medical Marijuana Patient Sues Wal-Mart Over Drug-Test Firing
D. Medical Reports Second Quarter 2010 Financial Results
Posted by admin on September 2nd, 2010Bloodgate doctor Wendy Chapman cleared by General Medical Council to practise …
Bloodgate doctor Wendy Chapman cleared by General Medical Council to practise medicine
Wendy Chapman, the doctor at the centre of the Bloodgate scandal, has been cleared to practise medicine by a General Medical Council disciplinary panel.
3 Die In Medical Helicopter Crash In Ark.
SCOTLAND, Ark. — Arkansas State Police say three people are dead in the crash of a medical helicopter in Van Buren County.
Family, Friends Remember The Life Of Paramedic
Spokesman Bill Sadler said the helicopter crashed near the town of Scotland, about 80 miles north of Little Rock, about 4:30 am Tuesday. Sadler said the helicopter crew was based in Vilonia and was flying to Alread to pick up a patient.
The crew, which included pilot Kenneth Robertson, flight nurse Kenneth Meyer, Jr., and flight paramedic Gayla Gregory, was en route to a scene flight at Crabtree, Ark. No patients were on board.
This is a tragic day for us here at Air Evac Lifeteam, said Air Evac Lifeteam President and CEO Seth Myers. These were members of our family and we are devastated at this loss. Our focus at this time is on providing support for the family and friends of these crew members.
The Hartford Names Dr. David Williams Medical Director of Underwriting
SIMSBURY, Conn., Aug 31, 2010 (BUSINESS WIRE) –
The Hartford has named Dr. David Williams medical director of its
Individual Life Insurance division. Dr. Williams will be responsible for
providing case consultation and training of the division’s 75
underwriters, who together assess nearly 80,000 life insurance
applications each year. He will report to Dr. Ann Hoven, assistant vice
president and chief medical director.
Dr. Williams, who is a Lieutenant Colonel in the Army Reserve, recently
returned from his third tour of duty as a physician in Iraq and
Afghanistan. He previously worked at AIG American General Domestic Life
Companies and at Ohio National as a vice president and medical director.
“Dr. Williams has the background and conviction to help The Hartford to
continue to push the boundaries of insurance underwriting,” Dr. Ann
Hoven said, “so that we can provide life insurance to those who want it,
as we continually reassess, innovate, and update our health and
mortality assessments.”
Dr. Williams earned his bachelor of arts degree in biology at Amherst
College in Amherst, Mass., and his master of business administration
(management) degree from Xavier University in Cincinnati, Ohio. His
doctor of medicine degree is from the University of Cincinnati College
of Medicine. He did his internship and residency in Internal Medicine at
The Christ Hospital, in Cincinnati, Ohio. He is Board Certified in both
internal medicine and insurance medicine and has attained the
designation as a Fellow from the Life Management Institute (FLMI). He
has published nearly 30 articles in the Journal of Insurance Medicine.
The Hartford was the first insurer in the nation to offer standard rates
on life insurance to women recovering from early stage breast cancer and
men who have been successfully treated for localized prostate cancer.
The company recently instituted changes in the way it assesses the
health and longevity of applicants and said that it expects the changes
to reduce the cost of premiums for a quarter of all new policyholders.
About The Hartford
Celebrating 200 years of helping its customers achieve what’s ahead, The
Hartford
/quotes/comstock/13*!hig/quotes/nls/hig
(HIG
20.17,
+0.58,
+2.95%)
is an insurance and wealth management company.
Through its unique focus on customer needs, the company serves
businesses and consumers by providing the products and solutions they
need to protect their assets and income from risks and manage their
wealth and retirement needs. A Fortune 100 company, The Hartford is
recognized widely for its service expertise and as one of the world’s
most ethical companies. More information on the company and its
financial performance is available at www.thehartford.com.
Over 750,000 Americans currently trust their life insurance needs to The
Hartford’s life subsidiaries, in part because they are getting more than
the promise of a death benefit. They are entrusting their financial
protection to a company that prides itself on integrity.
Some of the statements in this release may be considered forward-looking
statements as defined in the Private Securities Litigation Reform Act of
1995. We caution investors that these forward-looking statements are not
guarantees of future performance, and actual results may differ
materially. Investors should consider the important risks and
uncertainties that may cause actual results to differ. These important
risks and uncertainties include those discussed in our Quarterly Reports
on Form 10-Q, our 2007 Annual Report on Form 10-K and the other filings
we make with the Securities and Exchange Commission. We assume no
obligation to update this release, which speaks as of the date issued.
HIG — W
LIF — 101592 — 8/10
SOURCE: The Hartford
The Hartford
Robert DeMallie, 860-843-5215
Robert.DeMallie@hartfordlife.com
or
Timothy Benedict, 860-843-5150
Timothy.Benedict@hartfordlife.com
Copyright Business Wire 2010
Boosting the Use of Medical Alert Bling To Save Lives
Advances in medical alert bracelets and other ID systems can make it easier for medics and ER staff to quickly access vital data about patients who cant speak for themselves in an accident or emergency, todays Informed Patient column reports.
At least 60 million Americans are estimated to have a medical condition that should be known during an emergency. But only a fraction of those folks wear bracelets or carry any other type of medical information, including some of the newer methods like USB flash drives.
As part of an effort to get consumers to better prepare for medical emergencies, the American College of Emergency Physicians is launching a campaign, Seconds Saves Lives, with brochures to be distributed in 1,000 emergency rooms this fall. Among other things, the group advises people to carry a emergency medical ID card or wear medical ID jewelry if they have a health condition, allergy, implanted device or if they are taking medications that might be life-threatening in certain circumstances.
ACEP recommends using medical ID linked to a live emergency medical information service such as the non-profit MedicAlert Foundation. With 4 million members worldwide, the group offers jewelry engraved with a brief description of a patients condition and a 24/7 toll-free number. Operators can quickly access members data from electronic records that patients can update online. MedicAlert also has partnerships with drug chains including CVS to electronically transmit prescription drug and dosage information to patient records.
Consumers say the cost — about $30 a year — is well worth the peace of mind. Bob Hawkinson, a diabetic in Jacksonville, Fla., tells the Health Blog that a MedicAlert bracelet saved his life several years ago when someone came to his aid after an accident, saw the bracelet, and gave him a sports drink to keep his blood sugar under control until medics came along.
He now has an external insulin pump, which is noted on his bracelet. If I ever get in another car wreck and the pump gets ripped off, emergency responders will know I cant sit there for hours without insulin, says Hawkinson. Its a good insurance policy.
Photo: MedicAlert
Revolutions Medical Corporation Begins Clinical Applications and Validation …
CHARLESTON, S.C., Aug 16, 2010 (GlobeNewswire via COMTEX) –
Revolutions Medical Corporation (”Revolutions Medical” or the “Company”)
/quotes/comstock/11k!rmcp
(RMCP
0.43,
+0.05,
+13.16%)
, begins collaboration with H. Keith Brown, PhD, Philadelphia College of Osteopathic Medicine, on two clinical applications using their proprietary Magnetic Resonance software tools; RevDisplay, RevColor and Rev3D. One clinical application is for the differentiation and characterization of Intracranial Hemorrhages by Color MRI Automatic Segmentation and the other is for characterization of intracranial masses by Color MRI Automatic Segmentation.
Led by Professor of Anatomy, H. Keith Brown, PhD, these studies will be the first of their kind to examine the use of RevMed’s proprietary MRI software tools to enhance diagnostic confidence in the diagnosis of tumors, cysts, and other masses and to aid in distinguishing between older blood and new blood for concussions and other head injuries.
“To be working with the pioneer of color MRI, H. Keith Brown, PhD, on a project of this importance, means a great deal to all of us here at Revolutions Medical. We will now begin the validation process for the use of our MRI software tools through these first of many clinical applications to be delivered through our software as a service (SAS) model. We believe this process has the potential to add tremendous value to the company as we launch our tools into the marketplace,” stated Ron Wheet, CEO, Revolutions Medical.
About Revolutions Medical Corporation
Revolutions Medical is a safety medical device and software application company. Its products include the RevVac safety syringe (FDA approved), safety blood drawing device and safety IV catheter. The Company also provides RevColor, RevDisplay and Rev3D — software solutions and proprietary tools that are compatible with standard MRIs and standard PACS. The software suite’s functionality includes sorting of images, color, 3D and automatic segmentation of images.
For additional information about, please visit Revolutions Medical corporate website: http://www.revolutionsmedical.com
Investor Resource Center
Fact Sheet:
http://content.stockpr.com/rmcp/files/RMCP+-+Fact+Sheet+02-26-10.pdf
CEO Ron Wheet Audio Interview:
http://ir.stockpr.com/revolutionsmedical/media-center/view/33/
RevVac Demo Video:
http://revolutionsmedical.com/
To be added to the Revolutions Medical investor email list, please email Skey@revolutionsmedical.com with RMCP in the subject line.
Become a RevMed fan and follow the Company on Facebook - visit http://www.facebook.com/RevMed
FORWARD-LOOKING STATEMENTS
The information contained herein includes forward-looking statements. These statements relate to future events or to our future financial performance, and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements since they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond our control and which could, and likely will, materially affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects our current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to our operations, results of operations, growth strategy and liquidity. We assume no obligation to publicly update or revise these forward-looking statements for any reason, or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Additional information on risks and other factors that may affect the business and financial results of Revolutions Medical Corporation can be found in the Company’s periodic and other filings with the U.S. Securities and Exchange Commission.
This news release was distributed by GlobeNewswire, www.globenewswire.com
SOURCE: Revolutions Medical Corporation
CONTACT: Revolutions Medical Corporation
Investor Relations:
Scott Key
(843) 518-0437
skey@revolutionsmedical.com
(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.
Talking to Patients After a Medical Mistake
Families of patients who fall victim to medical errors often feel abandoned by the doctors who have been treating their loved one for weeks. Fears of litigation prompt hospitals to clamp down on all communication, and longtime doctor-patient relationships disappear overnight.
But does it have to be that way? In this weeks Doctor and Patient column, Dr. Pauline Chen writes about new efforts to restore communication with patients and their families after a medical error. She writes:
Since 2001, the University of Michigan Health System has handled patient injuries by initiating discussions with patients and families, conducting internal investigations and offering apologies with offers of compensation should those investigations reveal medical errors. To examine the repercussions of such an open disclosure with compensation policy, researchers analyzed the number of claims and lawsuits filed against the hospital system between 1995 and 2007, comparing data from before and after the policy took effect.
Contrary to fears that such transparency might worsen litigation, the researchers found that there were actually fewer lawsuits and claims after the hospital began its disclosure with compensation program. Moreover, the hospital system’s liability costs for lawsuits, patient compensation and legal fees dropped, and claims in general were resolved faster than ever before.
To learn more, read the full column, When Doctors Admit Their Mistakes, and then please join the discussion below.
BSD Medical wins FDA clearance for ablation system, drums up $2.75 million
BSD Medical Corp. lands 510(k) clearance from the Food amp; Drug Administration for its MTX-180 microwave ablation system and drums up $2.75 million in an offering of stock and warrants to a pair of its previous institutional investors.